Overview
CAMP market data
Price History
CAMP price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.65 Diluted earnings per share over the trailing twelve months.
- Beta
- -22.46 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.32 – $7.75 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $156.8 · P/B 6.67 · P/S 0.05.
Company news
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globenewswire Inc · Jun 19, 2026, 9:15 PM
W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jun 16, 2026, 12:30 PM
This Exxon Mobil Analyst Turns Bullish; Here Are Top 5 Upgrades For TuesdayBenzinga · Jun 16, 2026, 12:05 PM
8-K filing — Camp4 Therapeutics Corp (CAMP)SEC EDGAR · Jun 12, 2026, 8:10 PM